Ozempic, Coerced Weight-Loss, and Threats to Rationality
Keisha Ray
Over the last four years, GLP-1 agonists such as Ozempic, touted by many as miracle weight-loss drugs and popularized by celebrity culture, have seen a 700% increase in use among patients without diabetes. Their use for weight loss has more than doubled since early 2024. On November 6, 2025, the Trump administration announced that the cost of these drugs […] The post Ozempic, Coerced Weight-Loss, and Threats to Rationality appeared first on Bioethics Today .